↓ Skip to main content

Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme

Overview of attention for article published in Radiation Oncology, February 2013
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
32 Dimensions

Readers on

mendeley
83 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Phase I study of hypofractionated intensity modulated radiation therapy with concurrent and adjuvant temozolomide in patients with glioblastoma multiforme
Published in
Radiation Oncology, February 2013
DOI 10.1186/1748-717x-8-38
Pubmed ID
Authors

Noha Jastaniyah, Albert Murtha, Nadeem Pervez, Duc Le, Wilson Roa, Samir Patel, Marc Mackenzie, Dorcas Fulton, Colin Field, Sunita Ghosh, Gino Fallone, Bassam Abdulkarim

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 83 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 1%
Netherlands 1 1%
Italy 1 1%
Brazil 1 1%
Unknown 79 95%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 14%
Student > Bachelor 11 13%
Researcher 10 12%
Student > Doctoral Student 7 8%
Other 7 8%
Other 17 20%
Unknown 19 23%
Readers by discipline Count As %
Medicine and Dentistry 42 51%
Neuroscience 6 7%
Agricultural and Biological Sciences 4 5%
Engineering 4 5%
Nursing and Health Professions 2 2%
Other 5 6%
Unknown 20 24%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 March 2024.
All research outputs
#14,272,223
of 22,888,307 outputs
Outputs from Radiation Oncology
#808
of 2,060 outputs
Outputs of similar age
#110,768
of 193,258 outputs
Outputs of similar age from Radiation Oncology
#23
of 32 outputs
Altmetric has tracked 22,888,307 research outputs across all sources so far. This one is in the 35th percentile – i.e., 35% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,060 research outputs from this source. They receive a mean Attention Score of 2.7. This one has gotten more attention than average, scoring higher than 56% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,258 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 32 others from the same source and published within six weeks on either side of this one. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.